NuVasive Settles With DOJ On Medicare Fraud Charges
This article was originally published in The Gray Sheet
Executive Summary
The spine device firm announced a definitive settlement with the Department of Justice, with a fine of $13.5 million, plus fees and accrued interest
You may also be interested in...
NuVasive To Expand Global Presence, Product Portfolio With Ellipse Buy
NuVasive says Ellipse's magnetically adjustable implant systems will open new global markets, particularly in the pediatric space, and complement its current portfolio. Analysts say the move is positive, but at least one observer believes that NuVasive might have paid too much for the deal.
NuVasive Eyes Further Expansion In Spinal Market
NuVasive is determined to put the turmoil of recent months behind it. With a new management team in place, the company aims to become the market leader in spine through innovation and increased adoption of minimally invasive approaches.
Business Briefs
Hill-Rom's acquisition of Welch Allyn speeds ahead; Nuvasive builds its team; Philips divests pediatric respiratory products.